BackIntercure Overview

Intercure Receivables

Intercure's receivables is $150M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$154.47M
14.42% YoYΔ $-26.03M vs prior year quarter

Peer average

Loading

Intercure Receivables History

Loading

Intercure vs. peers: Receivables Comparison

Loading

Intercure Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Intercure (INCR) FAQ

As of the most recent data (December 2025), INCR shows a receivables of $150M. That compares with $180M in the prior-year period — down 14.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INCR's receivables is now $150M (was $180M) — a 14.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Intercure is outperforming or lagging.

Tracking INCR's receivables over time shows whether Intercure is scaling, shrinking, or reshaping that part of the business. The current reading is $150M That compares with $180M in the prior-year period — down 14.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Intercure's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $150M) with ownership activity and broader fundamentals.

Intercure's receivables is $150M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.